XML 45 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue recognition and accounts receivable (Tables)
3 Months Ended
Mar. 31, 2024
Revenue Recognition And Accounts Receivable [Abstract]  
Schedule of Net Sales by Major Product Category by Reporting Segment

The table below presents net sales by major product category by reporting segment:

 

 

 

Three Months Ended March 31,

 

(Unaudited, U.S. Dollars, in thousands)

 

2024

 

 

2023

 

 

Change

 

Bone Growth Therapies

 

$

52,477

 

 

$

47,714

 

 

 

10.0

%

Spinal Implants, Biologics, and Enabling Technologies

 

 

108,816

 

 

 

101,492

 

 

 

7.2

%

Global Spine

 

 

161,293

 

 

 

149,206

 

 

 

8.1

%

Global Orthopedics

 

 

27,315

 

 

 

25,998

 

 

 

5.1

%

Net sales

 

$

188,608

 

 

$

175,204

 

 

 

7.7

%

The table below presents net sales by major product category by reporting segment:

 

 

Three Months Ended March 31,

 

(Unaudited, U.S. Dollars, in thousands)

 

2024

 

 

2023

 

 

Change

 

Bone Growth Therapies

 

$

52,477

 

 

$

47,714

 

 

 

10.0

%

Spinal Implants, Biologics, and Enabling Technologies

 

 

108,816

 

 

 

101,492

 

 

 

7.2

%

Global Spine

 

 

161,293

 

 

 

149,206

 

 

 

8.1

%

Global Orthopedics

 

 

27,315

 

 

 

25,998

 

 

 

5.1

%

Net sales

 

$

188,608

 

 

$

175,204

 

 

 

7.7

%

Schedule of Components Net Sales

The table below presents product sales and marketing service fees, which are both components of net sales:

 

 

 

Three Months Ended March 31,

 

(Unaudited, U.S. Dollars, in thousands)

 

2024

 

 

2023

 

Product sales

 

$

175,831

 

 

$

162,248

 

Marketing service fees

 

 

12,777

 

 

 

12,956

 

Net sales

 

$

188,608

 

 

$

175,204

 

Allowances for Expected Credit Losses

The following table provides a detail of changes in the Company’s allowance for expected credit losses for the three months ended March 31, 2024 and 2023:

 

 

Three Months Ended March 31,

 

(Unaudited, U.S. Dollars, in thousands)

 

2024

 

 

2023

 

Allowance for expected credit losses beginning balance

 

$

7,130

 

 

$

6,419

 

Addition resulting from the Merger with SeaSpine

 

 

 

 

 

137

 

Current period provision for expected credit losses

 

 

1,376

 

 

 

208

 

Write-offs charged against the allowance and other

 

 

(19

)

 

 

(126

)

Effect of changes in foreign exchange rates

 

 

(89

)

 

 

53

 

Allowance for expected credit losses ending balance

 

$

8,398

 

 

$

6,691